← Back
Data updated: Jul 17, 2026
Omrix Biopharmaceuticals Ltd
Biotech Pharmaceuticals
Omrix Biopharmaceuticals Ltd is a biotechnology company with 2 FDA-approved products.
2003
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
Omrix Biopharmaceuticals Ltd's Key Drugs
Omrix Biopharmaceuticals Ltd's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
Omrix Biopharmaceuticals Ltd's Recent FDA Approvals
New NDA/BLA approvals for Omrix Biopharmaceuticals Ltd over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
Omrix Biopharmaceuticals Ltd's Therapeutic Areas
Disease areas where Omrix Biopharmaceuticals Ltd has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
Omrix Biopharmaceuticals Ltd Pipeline Snapshot
Active clinical trials for Omrix Biopharmaceuticals Ltd across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2003-03-20
- Latest
- 2007-08-26
- Applications
- 2